Lacrimal Apparatus Diseases
Showing 1 - 25 of >10,000
Epiphora, Ptosis Trial in New York (0.75% bupivacaine)
Withdrawn
- Epiphora
- Ptosis
- 0.75% bupivacaine
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 23, 2022
Epiphora, Dacryostenosis, Dacryocystitis Trial in New Orleans (Proparacaine Hydrochloride ophthalmic solution, USP 0.5%,
Recruiting
- Epiphora
- +2 more
- Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
- Balanced salt solution
-
New Orleans, LouisianaLouisiana State University Health Sciences Center
Dec 15, 2022
Corneal Disease, Blepharitis, Lacrimal Apparatus Diseases Trial in Saint Etienne (Handheld IVCM Vivascope 3000 (Caliber/Mavig)
Recruiting
- Corneal Disease
- +2 more
- Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml
- +2 more
-
Saint Etienne, Dermatology, France
- +1 more
Feb 9, 2022
Epiphora Due to Insufficient Drainage, Left Side, Epiphora Due to Insufficient Drainage, Right Side Trial in Tianjin
Recruiting
- Epiphora Due to Insufficient Drainage, Left Side
- Epiphora Due to Insufficient Drainage, Right Side
- Esophagogastric Side to Side Anastomosis
- Esophagogastric End to Side Anastomosis
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Apr 2, 2023
Design ofAugmented Reality System by Integration of CT Scan or
Recruiting
- Paranasal Sinus Diseases
- +2 more
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jul 8, 2021
Functional Epiphora (Tearing Without Any Anatomical Block) Trial in Hamilton, Istanbul (External Dacryocystorhinostomy,
Completed
- Functional Epiphora (Tearing Without Any Anatomical Block)
- External Dacryocystorhinostomy
- +2 more
-
Hamilton, Ontario, Canada
- +1 more
Jul 6, 2021
Epiphora, Dacryocystitis, Dacryocystocele Trial in Cairo (Endoscopic dacryocystorhinostomy)
Active, not recruiting
- Epiphora
- +2 more
- Endoscopic dacryocystorhinostomy
-
Cairo, EgyptAhmed ragab
Apr 2, 2021
Epiphora Trial in Kuwait (topical 0.05% CsA (Restasis®, Allergan Inc, Irvine, California)twice daily dose,)
Completed
- Epiphora
- topical 0.05% CsA (Restasis®, Allergan Inc, Irvine, California)twice daily dose,
-
Kuwait, Farwanyia, KuwaitFarwanyia Hospital
Nov 19, 2020
Epiphora Trial in Shibin Al Kawm (Placement of three interrupted sutures after Triangular Three-snip Punctoplasty of the lower
Unknown status
- Epiphora
- Placement of three interrupted sutures after Triangular Three-snip Punctoplasty of the lower punctum
- Conventional Triangular Three-snip Punctoplasty of the lower punctum
-
Shibīn Al Kawm, EgyptMenoufiaU
Dec 17, 2020
Lacrimal Apparatus Diseases Trial in Minya (Probing /irrigation of lacrimal passages)
Completed
- Lacrimal Apparatus Diseases
- Probing /irrigation of lacrimal passages
-
Minya, Minia, EgyptFaculty of Medicine
Jan 21, 2020
Lacrimal Duct Obstruction Trial in Tianjin (Dacryoendoscopic-assisted laser dacryoplasty with silicone intubation)
Recruiting
- Lacrimal Duct Obstruction
- Dacryoendoscopic-assisted laser dacryoplasty with silicone intubation
-
Tianjin, Tianjin, ChinaTianjin Eye Hospital
Aug 13, 2023
Lacrimal Passage Obstruction Trial in Minya (Dacryocystorhinostomy)
Completed
- Lacrimal Passage Obstruction
- Dacryocystorhinostomy
-
Minya, Minia, EgyptFaculty of Medicine
Jan 23, 2020
Epiphora Due to Insufficient Drainage Trial in Tanta (Methylprednisolone eyedrops)
Completed
- Epiphora Due to Insufficient Drainage
- Methylprednisolone eyedrops
-
Tanta, Gharbeyia, EgyptAmr Awara
Mar 23, 2020
Dry Eye Disease, Dry Eye, Kerato Conjunctivitis Sicca Trial in Catania (Cross-linked hyaluronic acid eye drops)
Recruiting
- Dry Eye Disease
- +3 more
- Cross-linked hyaluronic acid eye drops
-
Catania, CT, ItalyAzienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San
Apr 11, 2023
Nasolacrimal Duct Obstruction, Thyroid Cancer Trial (Artificial Tears Methylcellulose)
Not yet recruiting
- Nasolacrimal Duct Obstruction
- Thyroid Cancer
- Artificial Tears Methylcellulose
- (no location specified)
Aug 17, 2023
Lacrimal Duct Obstruction Trial in Hangzhou (Low temperature plasma lacrimal duct obstruction ablation combined with lacrimal
Recruiting
- Lacrimal Duct Obstruction
- Low temperature plasma lacrimal duct obstruction ablation combined with lacrimal duct catheterization
- YAG lacrimal duct laser combined with lacrimal duct catheter
-
Hangzhou, ChinaSecond Affiliated Hospital of Zhejiang University Hospital
Jun 27, 2021
Diseases of Mitral Valves, Abnormality of Mitral Valve Annulus (Disorder), Mitral Valve Replacement Trial in Ismailia (St.Jude
Completed
- Diseases of Mitral Valves
- +2 more
- St.Jude bi leaflet prosthetic mitral valve to replace the diseased valve with preservation of both leaflets
-
Ismailia, Egypt
- +1 more
Jun 23, 2022
Maxillary Sinus Disease, Approach-Approach Conflict Trial in Tanta (endoscopic maxillary mega-antrostomy, Endoscopic Modified
Recruiting
- Maxillary Sinus Disease
- Approach-Approach Conflict
- endoscopic maxillary mega-antrostomy
- +2 more
-
Tanta, Gharbia Government, EgyptFaculty of medicine
Aug 7, 2022
Dry Eye Syndromes, Keratoconjunctivitis Sicca, Lacrimal Apparatus Diseases Trial in Columbus (Systane Complete, Systane Ultra)
Completed
- Dry Eye Syndromes
- +7 more
- Systane Complete
- Systane Ultra
-
Columbus, OhioThe Ohio State University College of Optometry
May 22, 2019
Nasolacrimal Duct Obstruction
Completed
- Eye Diseases
- Lacrimal Duct Obstruction
- retrospective analyis
-
Vienna, AustriaMedical University of Vienna
Jun 18, 2021
Ophthalmopathy , Lacrimal System Trial in Sohag (5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline
Completed
- Ophthalmopathy , Lacrimal System
- 5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline hydrochloride, 2 mg Hydroxypropyl Methyl Cellulose, 10 mg α-tocopherol acetate and 8 mg macrogol 400).
- sodium hyaluronate, polyethylene and propylene glycol based) three times daily for three months
-
Sohag, EgyptSohag University
Sep 3, 2021
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,
Not yet recruiting
- Insulin Resistance
- +3 more
- Insulin human
- +11 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 6, 2023
Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)
Recruiting
- Insulin Resistance
- +4 more
- Insulin human
- +8 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 2, 2023
Epiphora Trial (insertion of self retaining bicanalicular stent)
Completed
- Epiphora
- insertion of self retaining bicanalicular stent
- (no location specified)
Nov 2, 2018
Evaporative Dry Eye Disease Trial in Valladolid (Lipiflow® application)
Completed
- Evaporative Dry Eye Disease
- Lipiflow® application
-
Valladolid, SpainInstituto Universitario de Oftalmobiología Aplicada (IOBA)
May 31, 2021